Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.
作者:
主题词
抗精神病药(Antipsychotic Agents);临床方案(Clinical Protocols);氯氮平(Clozapine);抗药性(Drug Resistance);药物疗法, 联合(Drug Therapy, Combination);政府调控(Government Regulation);氟哌啶醇(Haloperidol);人类(Humans);意大利(Italy);哌嗪类(Piperazines);前瞻性研究(Prospective Studies);喹诺酮类(Quinolones);研究设计(Research Design);精神分裂症(Schizophrenia);精神分裂症心理学(Schizophrenic Psychology);治疗结果(Treatment Outcome)
DOI
10.1186/1745-6215-10-31
PMID
19445659
发布时间
2023-11-05
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文